Abstract
A chromosome 1q21.3 region that is frequently amplified in diverse cancer types encodes phosphatidylinositol (PI)-4 kinase IIIβ (PI4KIIIβ), a key regulator of secretory vesicle biogenesis and trafficking. Chromosome 1q21.3-amplified lung adenocarcinoma (1q-LUAD) cells rely on PI4KIIIβ for Golgi-resident PI-4-phosphate (PI4P) synthesis, prosurvival effector protein secretion, and cell viability. Here, we show that 1q-LUAD cells subjected to prolonged PI4KIIIβ antagonist treatment acquire tolerance by activating an miR-218-5p-dependent competing endogenous RNA network that up-regulates PI4KIIα, which provides an alternative source of Golgi-resident PI4P that maintains prosurvival effector protein secretion and cell viability. These findings demonstrate an addiction to Golgi-resident PI4P synthesis in a genetically defined subset of cancers.
Original language | English (US) |
---|---|
Article number | e2023537118 |
Journal | Proceedings of the National Academy of Sciences of the United States of America |
Volume | 118 |
Issue number | 25 |
DOIs | |
State | Published - Jun 22 2021 |
Keywords
- Cancer
- Golgi
- Lipids
- Oncogene addiction
ASJC Scopus subject areas
- General
MD Anderson CCSG core facilities
- Advanced Technology Genomics Core
- Flow Cytometry and Cellular Imaging Facility
- Research Animal Support Facility
- Bioinformatics Shared Resource